Antifungals
Our multi-stakeholder group has developed good practice recommendations to optimise the use of antifungal medicines for patients with suspected fungal infections across three specialty areas: Critical Care, Haemato-oncology and Respiratory Medicine.
- Good Practice Recommendations for treatment of candidaemia and use of antifungal agents (pdf)
- Good Practice Recommendations on use of triazole antifungal agents in chronic respiratory disease (pdf)
- Good Practice Recommendations for antifungal stewardship in haemato-oncology